Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-31

Clinical Trial Update: The Effects of Exenatide After Gastric Restriction [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating Exenatide after gastric restriction in individuals with Morbid Obesity, spanning Phase 2 and Phase 3. The current status of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Advanced Specialty Care | Conditions: Morbid Obesity | Phase 2, Phase 3 | Status: UNKNOWN